Felis catus gut microbiota composition in rQS-78 infection and its treatment with GS-441524
this study aims to provide data on fecal microbiota composition in healthy, FIPV-infected, and treated cats, highlighting the growing understanding of microbiota alterations associated with FIPV infection and treatment. Understanding the interplay between FIPV, gut microbiota, and antiviral therapies could lead to more effective treatment strategies, including microbiota-based treatments or probiotics, targeted at restoring microbial balance and improving disease outcomes in affected cats.